FDA Reconsiders Weight Loss Drug Qnexa

The FDA is once again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take it.

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.